VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,188 | -25.0% | 2,685 | +16.3% | 0.00% | -33.3% |
| Q2 2023 | $54,907 | +5.4% | 2,308 | +12.8% | 0.00% | 0.0% |
| Q1 2023 | $52,076 | -23.8% | 2,047 | -12.5% | 0.00% | 0.0% |
| Q4 2022 | $68,351 | +109.3% | 2,340 | +47.0% | 0.00% | +50.0% |
| Q3 2022 | $32,652 | +77.3% | 1,592 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $18,419 | – | 1,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |